Bromodomain Factor 5 as a Target for Antileishmanial Drug Discovery
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bromodomain Factor 5 as a Target for Antileishmanial Drug Discovery
Authors
Keywords
-
Journal
ACS Infectious Diseases
Volume -, Issue -, Pages -
Publisher
American Chemical Society (ACS)
Online
2023-11-01
DOI
10.1021/acsinfecdis.3c00431
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TriTrypDB: An integrated functional genomics resource for kinetoplastida
- (2023) Achchuthan Shanmugasundram et al. PLoS Neglected Tropical Diseases
- Life in plastic, it’s fantastic! How Leishmania exploit genome instability to shape gene expression
- (2023) Jennifer A. Black et al. Frontiers in Cellular and Infection Microbiology
- Acetylation of histone H2B marks active enhancers and predicts CBP/p300 target genes
- (2023) Takeo Narita et al. NATURE GENETICS
- Bromodomain factor 5 is an essential regulator of transcription in Leishmania
- (2022) Nathaniel G. Jones et al. Nature Communications
- Identification of Histone Peptide Binding Specificity and Small-Molecule Ligands for the TRIM33α and TRIM33β Bromodomains
- (2022) Angelina R. Sekirnik et al. ACS Chemical Biology
- Anti-trypanosomatid drug discovery: progress and challenges
- (2022) Manu De Rycker et al. NATURE REVIEWS MICROBIOLOGY
- Visceral Leishmaniasis: Epidemiology, Diagnosis, and Treatment Regimens in Different Geographical Areas with a Focus on Pediatrics
- (2022) Sara Scarpini et al. Microorganisms
- Achieving clinical success with BET inhibitors as anti-cancer agents
- (2021) Tatiana Shorstova et al. BRITISH JOURNAL OF CANCER
- A systematic analysis of Trypanosoma brucei chromatin factors identifies novel protein interaction networks associated with sites of transcription initiation and termination
- (2021) Desislava P Staneva et al. GENOME RESEARCH
- Highly accurate protein structure prediction with AlphaFold
- (2021) John Jumper et al. NATURE
- AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models
- (2021) Mihaly Varadi et al. NUCLEIC ACIDS RESEARCH
- Expanding Bromodomain Targeting into Neglected Parasitic Diseases
- (2021) Cynthia Tallant et al. ACS Infectious Diseases
- Improvements on the quantitative analysis of Trypanosoma cruzi histone post translational modifications: Study of changes in epigenetic marks through the parasite's metacyclogenesis and life cycle
- (2020) Loyze Paola de Lima et al. Journal of Proteomics
- Selective targeting of BD1 and BD2 of the BET proteins in cancer and immuno-inflammation
- (2020) Omer Gilan et al. SCIENCE
- Fragment-Based Identification of Ligands for Bromodomain-Containing Factor 3 of Trypanosoma cruzi
- (2020) Corentine M. C. Laurin et al. ACS Infectious Diseases
- Small-Molecule Approaches to Targeted Protein Degradation
- (2020) Tyler B. Faust et al. Annual Review of Cancer Biology-Series
- Chemical epigenetics: the impact of chemical- and chemical biology techniques on bromodomain target validation
- (2019) Matthias Schiedel et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition
- (2019) Susan Wyllie et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bromodomains: a new target class for drug development
- (2019) Andrea G. Cochran et al. NATURE REVIEWS DRUG DISCOVERY
- Emerging tools to investigate bromodomain functions
- (2019) Pata-Eting Kougnassoukou Tchara et al. METHODS
- Small molecules as tools to study the chemical epigenetics of lysine acetylation
- (2018) Matthias Schiedel et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Molecular targets and pathways for the treatment of visceral leishmaniasis
- (2018) Vineet Jain et al. DRUG DISCOVERY TODAY
- Genetically Validated Drug Targets in Leishmania: Current Knowledge and Future Prospects
- (2018) Nathaniel G. Jones et al. ACS Infectious Diseases
- Overview of refinement procedures within REFMAC5: utilizing data from different sources
- (2018) Oleg Kovalevskiy et al. Acta Crystallographica Section D-Structural Biology
- Leishmaniasis
- (2018) Sakib Burza et al. LANCET
- Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis
- (2018) Susan Wyllie et al. NATURE
- Bromodomains in Protozoan Parasites: Evolution, Function, and Opportunities for Drug Development
- (2017) Victoria Jeffers et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need
- (2017) Mark C. Field et al. NATURE REVIEWS MICROBIOLOGY
- Functions of bromodomain-containing proteins and their roles in homeostasis and cancer
- (2017) Takao Fujisawa et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- HAT2 mediates histone H4K4 acetylation and affects micrococcal nuclease sensitivity of chromatin in Leishmania donovani
- (2017) Pravin K. Jha et al. PLoS One
- Shape, form, function and Leishmania pathogenicity: from textbook descriptions to biological understanding
- (2017) Jack Sunter et al. Open Biology
- Cell cycle stage-specific transcriptional activation of cyclins mediated by HAT2-dependent H4K10 acetylation of promoters in Leishmania donovani
- (2017) Udita Chandra et al. PLoS Pathogens
- Isoxazole-Derived Amino Acids are Bromodomain-Binding Acetyl-Lysine Mimics: Incorporation into Histone H4 Peptides and Histone H3
- (2016) Angelina R. Sekirnik née Measures et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Drugging the undruggables: exploring the ubiquitin system for drug development
- (2016) Xiaodong Huang et al. CELL RESEARCH
- Clinical progress and pharmacology of small molecule bromodomain inhibitors
- (2016) Natalie H Theodoulou et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Overexpression of bromodomain factor 3 inTrypanosoma cruzi(TcBDF3) affects differentiation of the parasite and protects it against bromodomain inhibitors
- (2016) Victoria Lucia Alonso et al. FEBS Journal
- Promiscuous targeting of bromodomains by bromosporine identifies BET proteins as master regulators of primary transcription response in leukemia
- (2016) S. Picaud et al. Science Advances
- Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 Inhibition
- (2015) Natalie H. Theodoulou et al. JOURNAL OF MEDICINAL CHEMISTRY
- HAT3-mediated acetylation of PCNA precedes PCNA monoubiquitination following exposure to UV radiation in Leishmania donovani
- (2015) D. Kumar et al. NUCLEIC ACIDS RESEARCH
- Bromodomain Proteins Contribute to Maintenance of Bloodstream Form Stage Identity in the African Trypanosome
- (2015) Danae Schulz et al. PLOS BIOLOGY
- Acetyl-lysine Binding Site of Bromodomain-Containing Protein 4 (BRD4) Interacts with Diverse Kinase Inhibitors
- (2014) Stuart W. J. Ember et al. ACS Chemical Biology
- Small Molecule Inhibitors of Bromodomain–Acetyl-lysine Interactions
- (2014) Michael Brand et al. ACS Chemical Biology
- Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains
- (2014) Duncan A. Hay et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Dual kinase-bromodomain inhibitors for rationally designed polypharmacology
- (2014) Pietro Ciceri et al. Nature Chemical Biology
- Optimization of 3,5-Dimethylisoxazole Derivatives as Potent Bromodomain Ligands
- (2013) David S. Hewings et al. JOURNAL OF MEDICINAL CHEMISTRY
- MTSA—A Matlab program to fit thermal shift data
- (2012) Michèle N. Schulz et al. ANALYTICAL BIOCHEMISTRY
- Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family
- (2012) Panagis Filippakopoulos et al. CELL
- The bromodomain interaction module
- (2012) Panagis Filippakopoulos et al. FEBS LETTERS
- The histone acetyl transferase LdHAT1 fromLeishmania donovaniis regulated by S-phase cell cycle kinase
- (2012) Anup Kumar Maity et al. FEMS MICROBIOLOGY LETTERS
- Progress in the Development and Application of Small Molecule Inhibitors of Bromodomain–Acetyl-lysine Interactions
- (2012) David S. Hewings et al. JOURNAL OF MEDICINAL CHEMISTRY
- Epigenetic protein families: a new frontier for drug discovery
- (2012) Cheryl H. Arrowsmith et al. NATURE REVIEWS DRUG DISCOVERY
- Bromodomains: Are Readers Right for Epigenetic Therapy?
- (2012) Stuart J. Conway ACS Medicinal Chemistry Letters
- Presenting your structures: theCCP4mgmolecular-graphics software
- (2011) S. McNicholas et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticity
- (2011) Robert J. Young et al. DRUG DISCOVERY TODAY
- Bromodomains as therapeutic targets
- (2011) Susanne Muller et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- 3,5-Dimethylisoxazoles Act As Acetyl-lysine-mimetic Bromodomain Ligands
- (2011) David S. Hewings et al. JOURNAL OF MEDICINAL CHEMISTRY
- Histone H4 lysine 14 acetylation in Leishmania donovani is mediated by the MYST-family protein HAT4
- (2011) D. Kumar et al. MICROBIOLOGY-SGM
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Fast and accurate algorithm for the simulation of NMR spectra of large spin systems
- (2010) Andrés M. Castillo et al. JOURNAL OF MAGNETIC RESONANCE
- Molecular replacement withMOLREP
- (2009) Alexei Vagin et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Histone acetylations mark origins of polycistronic transcription in Leishmania major
- (2009) Sean Thomas et al. BMC GENOMICS
- Four histone variants mark the boundaries of polycistronic transcription units in Trypanosoma brucei
- (2009) T. N. Siegel et al. GENES & DEVELOPMENT
- xia2: an expert system for macromolecular crystallography data reduction
- (2009) G. Winter JOURNAL OF APPLIED CRYSTALLOGRAPHY
- www.nmrdb.org: Resurrecting and Processing NMR Spectra On-line
- (2008) Damiano Banfi et al. CHIMIA
- Combinatorial patterns of histone acetylations and methylations in the human genome
- (2008) Zhibin Wang et al. NATURE GENETICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started